Literature DB >> 17363902

Suppressor of cytokine signaling 3 controls lysosomal routing of G-CSF receptor.

Mahban I Irandoust1, Lambertus H J Aarts, Onno Roovers, Judith Gits, Stefan J Erkeland, Ivo P Touw.   

Abstract

The hematopoietic system provides an attractive model for studying growth factor-controlled expansion and differentiation of cells in relation to receptor routing and its consequences for signal transduction. Suppressor of cytokine signaling (SOCS) proteins regulate receptor signaling partly via their ubiquitin ligase (E3)-recruiting SOCS box domain. Whether SOCS proteins affect signaling through modulating intracellular trafficking of receptors is unknown. Here, we show that a juxtamembrane lysine residue (K632) of the granulocyte colony-stimulating factor receptor (G-CSFR) plays a key role in receptor routing and demonstrate that the effects of SOCS3 on G-CSF signaling to a major extent depend on this lysine. Mutation of K632 causes accumulation of G-CSFR in early endosomes and leads to sustained activation of signal transducer and activator of transcription 5 and ERK, but not protein kinase B. Myeloid progenitors expressing G-CSFR mutants lacking K632 show a perturbed proliferation/differentiation balance in response to G-CSF. This is the first demonstration of SOCS-mediated ubiquitination and routing of a cytokine receptor and its impact on maintaining an appropriate signaling output.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17363902      PMCID: PMC1847666          DOI: 10.1038/sj.emboj.7601640

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  49 in total

1.  Tyrosine-dependent and -independent mechanisms of STAT3 activation by the human granulocyte colony-stimulating factor (G-CSF) receptor are differentially utilized depending on G-CSF concentration.

Authors:  A C Ward; M H Hermans; L Smith; Y M van Aesch; A M Schelen; C Antonissen; I P Touw
Journal:  Blood       Date:  1999-01-01       Impact factor: 22.113

2.  G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes.

Authors:  Mutsuo Harada; Yingjie Qin; Hiroyuki Takano; Tohru Minamino; Yunzeng Zou; Haruhiro Toko; Masashi Ohtsuka; Katsuhisa Matsuura; Masanori Sano; Jun-ichiro Nishi; Koji Iwanaga; Hiroshi Akazawa; Takeshige Kunieda; Weidong Zhu; Hiroshi Hasegawa; Keita Kunisada; Toshio Nagai; Haruaki Nakaya; Keiko Yamauchi-Takihara; Issei Komuro
Journal:  Nat Med       Date:  2005-02-20       Impact factor: 53.440

3.  Functional properties of leptin receptor isoforms: internalization and degradation of leptin and ligand-induced receptor downregulation.

Authors:  S Uotani; C Bjørbaek; J Tornøe; J S Flier
Journal:  Diabetes       Date:  1999-02       Impact factor: 9.461

4.  Proliferation signaling and activation of Shc, p21Ras, and Myc via tyrosine 764 of human granulocyte colony-stimulating factor receptor.

Authors:  J P de Koning; A A Soede-Bobok; A M Schelen; L Smith; D van Leeuwen; V Santini; B M Burgering; J L Bos; B Lowenberg; I P Touw
Journal:  Blood       Date:  1998-03-15       Impact factor: 22.113

5.  Multiple signals mediate proliferation, differentiation, and survival from the granulocyte colony-stimulating factor receptor in myeloid 32D cells.

Authors:  A C Ward; L Smith; J P de Koning; Y van Aesch; I P Touw
Journal:  J Biol Chem       Date:  1999-05-21       Impact factor: 5.157

6.  Janus kinases affect thrombopoietin receptor cell surface localization and stability.

Authors:  Yohan Royer; Judith Staerk; Marcel Costuleanu; Pierre J Courtoy; Stefan N Constantinescu
Journal:  J Biol Chem       Date:  2005-05-16       Impact factor: 5.157

7.  Defective internalization and sustained activation of truncated granulocyte colony-stimulating factor receptor found in severe congenital neutropenia/acute myeloid leukemia.

Authors:  A C Ward; Y M van Aesch; A M Schelen; I P Touw
Journal:  Blood       Date:  1999-01-15       Impact factor: 22.113

8.  Deletion of a critical internalization domain in the G-CSFR in acute myelogenous leukemia preceded by severe congenital neutropenia.

Authors:  M G Hunter; B R Avalos
Journal:  Blood       Date:  1999-01-15       Impact factor: 22.113

9.  Identification of a novel ubiquitin conjugation motif, required for ligand-induced internalization of the growth hormone receptor.

Authors:  R Govers; T ten Broeke; P van Kerkhof; A L Schwartz; G J Strous
Journal:  EMBO J       Date:  1999-01-04       Impact factor: 11.598

10.  Feedback inhibition of leptin receptor/Jak2 signaling via Tyr1138 of the leptin receptor and suppressor of cytokine signaling 3.

Authors:  Sarah L Dunn; Marie Björnholm; Sarah H Bates; Zhibin Chen; Matthew Seifert; Martin G Myers
Journal:  Mol Endocrinol       Date:  2004-12-16
View more
  38 in total

Review 1.  Erythropoietin receptor response circuits.

Authors:  Don M Wojchowski; Pradeep Sathyanarayana; Arvind Dev
Journal:  Curr Opin Hematol       Date:  2010-05       Impact factor: 3.284

2.  Deletion of the SOCS box of suppressor of cytokine signaling 3 (SOCS3) in embryonic stem cells reveals SOCS box-dependent regulation of JAK but not STAT phosphorylation.

Authors:  Kristy Boyle; Jian-Guo Zhang; Sandra E Nicholson; Evelyn Trounson; Jeffery J Babon; Edward J McManus; Nicos A Nicola; Lorraine Robb
Journal:  Cell Signal       Date:  2008-11-12       Impact factor: 4.315

3.  Alternatively spliced, truncated GCSF receptor promotes leukemogenic properties and sensitivity to JAK inhibition.

Authors:  H M Mehta; M Futami; T Glaubach; D W Lee; J R Andolina; Q Yang; Z Whichard; M Quinn; H F Lu; W M Kao; B Przychodzen; C A Sarkar; A Minella; J P Maciejewski; S J Corey
Journal:  Leukemia       Date:  2013-10-30       Impact factor: 11.528

Review 4.  Mechanisms of leukemic transformation in congenital neutropenia.

Authors:  Daniel C Link
Journal:  Curr Opin Hematol       Date:  2019-01       Impact factor: 3.284

5.  Prevalence of a new auto-activating colony stimulating factor 3 receptor mutation (CSF3R-T595I) in acute myeloid leukemia and severe congenital neutropenia.

Authors:  Renée Beekman; Marijke Valkhof; Paulette van Strien; Peter J M Valk; Ivo P Touw
Journal:  Haematologica       Date:  2013-03-18       Impact factor: 9.941

Review 6.  Neuroprotection through G-CSF: recent advances and future viewpoints.

Authors:  Vikrant Rahi; Sumit Jamwal; Puneet Kumar
Journal:  Pharmacol Rep       Date:  2021-01-02       Impact factor: 3.024

7.  MiR-17/20/93/106 promote hematopoietic cell expansion by targeting sequestosome 1-regulated pathways in mice.

Authors:  Annemarie Meenhuis; Peter A van Veelen; Hans de Looper; Nicole van Boxtel; Iris J van den Berge; Su M Sun; Erdogan Taskesen; Patrick Stern; Arnoud H de Ru; Arjan J van Adrichem; Jeroen Demmers; Mojca Jongen-Lavrencic; Bob Löwenberg; Ivo P Touw; Phillip A Sharp; Stefan J Erkeland
Journal:  Blood       Date:  2011-05-31       Impact factor: 22.113

Review 8.  SOCS regulation of the JAK/STAT signalling pathway.

Authors:  Ben A Croker; Hiu Kiu; Sandra E Nicholson
Journal:  Semin Cell Dev Biol       Date:  2008-07-30       Impact factor: 7.727

9.  Transregulation of leukemia inhibitory [corrected] factor receptor expression and function by growth factors in neuroblastoma cells.

Authors:  Martha D Port; George S Laszlo; Neil M Nathanson
Journal:  J Neurochem       Date:  2008-07-04       Impact factor: 5.372

10.  Mechanism of attenuation of leptin signaling under chronic ligand stimulation.

Authors:  Holger Knobelspies; Julia Zeidler; Paul Hekerman; Simone Bamberg-Lemper; Walter Becker
Journal:  BMC Biochem       Date:  2010-01-08       Impact factor: 4.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.